eli lilly tirzepatide drug reduces diabetes risk and sustains weight loss, study says Lilly's tirzepatide cuts diabetes risk,

Radenkovic, D., Reason, & Verdin, E

Available online at: 232 SohnS.-I.PriyaA.BalasubramaniamB.MuthuramalingamP.SivasankarC.SelvarajA.et al (2021)

We showed that senescent cells are primed for ferroptosis and that targeting GPX4 unlocks a vulnerability of senescent cells that can be exploited for therapeutic benefit

A Phase 2a study evaluating mebendazole (polymorphism C) in patients with advanced gastrointestinal cancer treated patients with up to 4g/day mebendazole with a target serum concentration of 300ng/mL

Kishore M

The trend of older adults seeking supplements to improve their health and lessen age-related health problems is a result of the aging population, as well as their propensity for self-medication and preventive healthcare